Current Gene Therapy : Impact Factor & More
eISSN: 1875-5631pISSN: 1566-5232
Share this on:
Aims and Scope of Current Gene Therapy
Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Liang Cheng (Harbin Medical University Harbin, China). The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters"). Less
Key Metrics
CiteScore 
5.8
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Genetics
SNIP
0.89
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Gene Therapy
Current Gene Therapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Gene Therapy
Shaping the Future of Prostate Cancer Care: The Promise and Pitfalls of Gene- and Cell-Based Therapeutics.
- 17 Apr 2026
- Current gene therapy
Gene Therapy as a Novel Strategy for Alzheimer’s Disease: Efficacy and Long-Term Implications
- 8 Apr 2026
- Current Gene Therapy
Evaluation of the Cellular Effects of miR-30d-3p in A549 Cells Under Normoxic and Hypoxic Conditions
- 7 Apr 2026
- Current Gene Therapy
Transcription Factor EB Drives Thrombospondin-1 Expression to Dampen Focal-adhesion Signaling and Limit Post-infarction Cardiac Fibrosis.
- 3 Apr 2026
- Current gene therapy
Decoding Programmed Cell Death Genes: Innovations in Cancer Diagnosis and Treatment.
- 30 Mar 2026
- Current gene therapy
CFTR mRNA-Based Gene Therapy for Cystic Fibrosis: A Mutation-Agnostic Strategy to Restore Ion Transport Function.
- 25 Mar 2026
- Current gene therapy
Shaping the Future of Prostate Cancer Care: The Promise and Pitfalls of Gene- and Cell-Based Therapeutics.
- 17 Apr 2026
- Current gene therapy
Gene Therapy as a Novel Strategy for Alzheimer’s Disease: Efficacy and Long-Term Implications
- 8 Apr 2026
- Current Gene Therapy
Evaluation of the Cellular Effects of miR-30d-3p in A549 Cells Under Normoxic and Hypoxic Conditions
- 7 Apr 2026
- Current Gene Therapy
Transcription Factor EB Drives Thrombospondin-1 Expression to Dampen Focal-adhesion Signaling and Limit Post-infarction Cardiac Fibrosis.
- 3 Apr 2026
- Current gene therapy
Decoding Programmed Cell Death Genes: Innovations in Cancer Diagnosis and Treatment.
- 30 Mar 2026
- Current gene therapy
CFTR mRNA-Based Gene Therapy for Cystic Fibrosis: A Mutation-Agnostic Strategy to Restore Ion Transport Function.
- 25 Mar 2026
- Current gene therapy
FAQs on Current Gene Therapy
How long has Current Gene Therapy been actively publishing? 
What is the publishing frequency of Current Gene Therapy?
How many articles did Current Gene Therapy publish last year?
What is the eISSN & pISSN for Current Gene Therapy?
What is Citescore for Current Gene Therapy?
What is SNIP score for Current Gene Therapy?
What is the SJR for Current Gene Therapy?
Who is the publisher of Current Gene Therapy?
